Related Experiment Video

Updated: Oct 22, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K

Multiomic Approaches to Uncover the Complexities of Dystrophin-Associated Cardiomyopathy

Aoife Gowran1, Maura Brioschi2, Davide Rovina1

  • 1Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino-IRCCS, 20138 Milan, Italy.

International Journal of Molecular Sciences
|August 27, 2021
PubMed

Insights

Duchenne cardiomyopathy (DAC) lacks targeted treatments due to complex mechanisms. Combining multiomics with precision models offers a promising path for developing effective therapies for this severe condition.

Area of Science:

  • Cardiology
  • Genetics
  • Biochemistry

Background:

  • Dystrophinopathies primarily affect skeletal muscle, but cardiomyopathy is a leading cause of mortality.
  • Current treatments for dystrophin-associated cardiomyopathy (DAC) are limited, with a significant unmet need for targeted therapies.
  • Progress in understanding and treating DAC is hindered by challenges in identifying key pathophysiological mechanisms and effective therapeutic targets.

Purpose of the Study:

  • To review fundamental discoveries in preclinical models of DAC.
  • To explore the integration of multiomic analyses in understanding DAC.
  • To highlight new perspectives for addressing unanswered questions in DAC occurrence and severity.

Main Methods:

  • Review of existing literature on preclinical models of DAC.
  • Analysis of how multiomic approaches have been applied to DAC research.
  • Integration of findings from advanced preclinical precision models.

Main Results:

  • Identified key pathophysiological mechanisms in DAC using various models.
  • Demonstrated the utility of multiomic analyses in uncovering novel insights into DAC.
  • Highlighted the potential of precision models in advancing DAC research.

Conclusions:

  • Multiomic analysis combined with advanced preclinical models offers a promising strategy for DAC therapy breakthroughs.
  • Further research is needed to validate these approaches and translate findings into clinical applications.
  • Addressing the complexities of DAC requires innovative methodologies and a deeper understanding of its underlying mechanisms.

Keywords:
dystrophin-associated cardiomyopathydystrophinopathiesmultiomic analysismuscular dystrophypreclinical precision models

More Related Videos

Dissection of Drosophila melanogaster Flight Muscles for Omics Approaches08:33

Dissection of Drosophila melanogaster Flight Muscles for Omics Approaches

Published on: October 17, 2019

12.3K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.2K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
84
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
97
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
121
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
131